Michelle J Henderson
8PUBLICATIONS
28CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 06, 2024
The third generation AKR1C3-activated prodrug, ACHM-025, eradicates disease in preclinical models of aggressive T-cell acute lymphoblastic leukemia.Cara E Toscan, Hannah McCalmont, Amir Ashoorzadeh
|Jun 01, 2022
Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.Nicola C Venn, Libby Huang, Lenka Hovorková
|Sep 02, 2021
Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.Vinod Vijay Subhash, Libby Huang, Alvin Kamili
|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.Lin Xiao, Klaartje Somers, Jayne Murray
|Apr 10, 2021
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.Mawar Karsa, Angelika Kosciolek, Angelika Bongers
|Apr 12, 2020
ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancer.Moonsun Jung, Jixuan Gao, Leanna Cheung
Pageof 2
Frequent Collaborators
4 joint publications
Chelsea Mayoh
3 joint publications
Toby N Trahair
3 joint publications
Murray D Norris
2 joint publications
Klaartje Somers
2 joint publications
Mark J Cowley
2 joint publications
Jamie I Fletcher
1 joint publications
Moonsun Jung
1 joint publications
Rachael Terry
1 joint publications
Anahid Ehteda
1 joint publications
Katerina I Leonova
